Navigation Links
Use of FlashPlate Technology for In Vitro Measurement of 125I-Labeled TGF-1 Binding on Chimeric Extracellular Domain of Type II Transforming Growth Factor Receptor

I-labeled TGF-1 (Specific activity 3,000-4,500 Ci/mmole, NEX267) was diluted in binding buffer just prior to its addition into the wells. The final concentrations of 125I-labeled TGF-1 ranged from 50 pM to 2.5 nM. The plates were incubated at room temperature for two hours, then sealed and counted on a Packard Top Count Microplate Scintillation Counter. A one minute counting period was used. All determinations were carried out at least in duplicate. Nonspecific binding was determined with an excess of unlabeled TGF-1 (100-fold). The counting efficiency was determined through the use of 125I-labeled IgG directly coated into Protein A FlashPlates. The cpm obtained at equilibrium, divided by the dpm added to the well, gave a measure of the counting efficiency, which was evaluated at 5%. For the competition binding assay, the final concentration of radiolabeled ligand was 500 pM (specific activity 300-450 Ci/mmole), with final concentrations ranging from 0.05 to 200 nM for TGF-1, TGF-2 and TGF-3.

Binding of 125I-labeled TGF-1 to cell: Ligand binding of cell monolayers with 125I-labeled TGF-1 (20 pM to 1 nM) were carried out as previously described3, then scatchard plotted with values obtained after gamma scintillation counting. Scatchard experiments were performed on Cos-1 cells (American Type Culture Collection CRL1650) transiently transfected either with the TRII (pCMV5 TRII), or with both TRI and TRII containing plasmids (pCMV5 TRI + pCMV5 TRII), and compared to Cos-1 cells transfected with the empty pCMV5 (Invitrogen) in order to measure the nonspecific binding.

Results

Comparative studies on binding of 125I-labeled TGF-1 to human TRIIs-Fc and wild type TRII: Ligand binding activity of the recombinant hTRIIs-Fc receptor was tested in a Protein A FlashPlate binding assay. Protein A precoated plastic surface
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Counting FlashPlates on the Wallac MicroBeta
2. Use of FlashPlate Technology for In Vitro Measurement of [35S]-GTPγS Binding in CHO Cells Expressing the Human 5-HT1B Receptor
3. Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors
4. In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate
5. Evaluation of FlashPlate in a Helicase Assay
6. Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
7. Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep Technology
8. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
9. DNA purification from pig ears to bird blood using proven DNeasy Technology
10. Near Infrared Technology and Optical Agents For Molecular Imaging
11. In-Vitro Metabolism Studies Using Data-Dependent LC/MSn
Post Your Comments:
(Date:7/24/2008)...uly 24 /- The Global Probiotics Counc...e DANONE and Yakult Honsha,Co., Ltd., announced th...g,Investigator Grant for Probiotics Research (YIGP...ng rising stars who will continue to contribute to...research in the United,States., Ajay S. Gulati, M...
(Date:7/24/2008)...O, Calif., July 24 /- Ponia...armaceutical company focused,on oncology, today an...cuss,the Company,s second quarter results and prov... clinical development plan for picoplatin, the,Com...., chairman and chief,executive officer, Ronald A....
(Date:7/24/2008)...ly 24 /- Cara Therapeutics, Inc.,anno... additional funding,to its original $24 million Se...round was led by new investor, Devon Park Bioventu...ovations. Previous investors participating,in the ...ishi International,Corporation and Wistar Morris. ...
(Date:7/24/2008)...July 24 /- Sagent Pharmaceuticals, In...any, today announced that it,has launched ceftazid...trum, beta-lactam antibiotic. Sagent will offer ce...rmacy bulk package vials. According to,IMS data, 2...tates were,approximately $45.7 million., "Sagent ...
Breaking Biology Technology:Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 2Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 3Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 4Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31 2Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2
...tal investments during 2005 in the biotech and med...pared against the general VC landscape. I also pro...ure Capital investments by region and stage of dev...for this analysis is provided once again by Price...probably useful for us to benchmark the Midwest ag...
... which makes computerized assessment and progress ...n Wednesday that president and CEO John Hickey, 50...nd CEO since 2003. , ,"There is never a right tim...ess release. "I know some people will be surprised...g I have been thinking about for some time. At 50 ...
...atement, consider this pledge from the bipartisan ...will not simply propose adding new dollars on top ...se of all dollars first those currently in the (K... dollars if that is the finding of the adequacy an...ive] , ,In other words, this blue-ribbon panel wo...
...spoke of energy during a visit to Wisconsin, but r...rces, his remarks were directed toward new methods... to foreign oil. , ,In an address before employees... battery manufacturer that is developing a new fue...y initiative he outlined during the State of the U...
Other Biology Technology:Midwest plays small role in VC investment, angel groups to the rescue 2Midwest plays small role in VC investment, angel groups to the rescue 3Midwest plays small role in VC investment, angel groups to the rescue 4Midwest plays small role in VC investment, angel groups to the rescue 5Measuring what works and what doesn't in the prototypical school 2Measuring what works and what doesn't in the prototypical school 3Bush praises Johnson Controls battery tech in Milwaukee visit 2
(Date:7/24/2008)... telescope promise to make it easier for people wi...s requiring sharper distance vision. Schepens Eye ...ges of these innovative glasses over earlier devic...f Journal of Biomedical Optics , mailed in print...sign has several advantages," says the inventor of...
(Date:7/24/2008)...udy by researchers from Columbia University,s Mail...ost challenging issues in infant health and preven...tries. In these settings, HIV-infected mothers ha... infants, they should exclusively breast-feed, fol...birth. But according to the study conducted in Lus...
(Date:7/24/2008)...sylvania State University College of Medicine, Her...cy of imiquimod, a clinically important immune res... activity, is dependent on the Opioid Growth Facto...This discovery, reported in the August 08 issue of... insights into a widely used drug that may lead to...
(Date:7/24/2008)...entists at Harvard University and the University o...n is strongly shaped by genes, efforts to prevent ...r study also suggests that the cost of errors in p...s themselves, rather than the loss of functional p...ived cells, like neurons, and cause neurodegenerat...
Breaking Biology News(10 mins):Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Various species' genes evolve to minimize protein production errors 2Various species' genes evolve to minimize protein production errors 3Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca 1804 1Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca 1804 2Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca 1804 3Computerized Jump Rope Raises Funds for Breast Cancer Research 1800 1Computerized Jump Rope Raises Funds for Breast Cancer Research 1800 2Symbollon Pharmaceuticals Inc Evaluates the Clinical Effects of IoGen 28TM 29 on Fibrocystic Breast Disease 361 1Symbollon Pharmaceuticals Inc Evaluates the Clinical Effects of IoGen 28TM 29 on Fibrocystic Breast Disease 361 2Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency 1793 1Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency 1793 2Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency 1793 3
...vered three molecules –?from a search of 58,000 co... of Alzheimer,s disease. , Each of the three molec...mes hopelessly tangled in the brains of patients w... the development of drugs for the disease. , Ken ...stitute at the University of California, Santa Bar...
... the mechanism by which the new genetically engine...d to the Vakzine Projekt Management who will test ...mechanisms for the high efficacy of this vaccine h...igations, August 18, 2005). , Globally, tuberculo...ver, multi-drug-resistant tuberculosis strains are...
...ists led by The Burnham Institute,s Maurizio Pelle...hrax toxin, termed lethal factor ("LF") that could...sure to inhalation anthrax. These findings will be...emy of Sciences by Early Edition at the journal,s ...s ("anthrax") is a proven agent of biological terr...
...rs, or Sultans of Soil, they,re just clever Lab gu... a paper in this week,s Science Magazine with a ne... the highly complex world beneath our feet. , "Com...ersity and High Metal Toxicity in Soil," by Jason ...os, Bioscience Division, describes a new approach ...
Other Biology News:Scientists discover that three molecules may be developed into new Alzheimer's drugs 2Scientists discover that three molecules may be developed into new Alzheimer's drugs 3Anthrax inhibitors identified by Burnham team 2Anthrax inhibitors identified by Burnham team 3Comparison of Cocaine, Methamphetamine ‘Highs?Finds Differences 2
from yeast/leuconostoc overproducer ATP: D-hexose 6- phosphotransferase/D-glucose-6-phosphate: NADP 1-oxidoreductase EC 2.7.1.1/1.1.1.49. One unit of HK will phosphorylate 1 mol of D-glucose in 1 min
Request Info
Pyruvate Kinase. This product is expected to react with pyruvate kinase from other mammalian species but has not been specifically determined. Specificity: Gives a single precipitin line against pa
Features Convenient platform for tube handling and reagent dispensing Holds: - 96 x 0.2ml V-bottom tubes - 96 x 0.3ml U-bottom Omnistrips - Thermo-Tube Plates - Thermo-Fast®
Biology Products: